Copper Sulfide Perfluorocarbon Nanodroplets as Clinically Relevant Photoacoustic/Ultrasound Imaging Agents.

We have developed laser-activated perfluorocarbon nanodroplets containing copper sulfide nanoparticles (CuS NPs) for contrast-enhanced ultrasound and photoacoustic imaging. As potential clinical contrast agents, CuS NPs have favorable properties including biocompatibility, biodegradability, and enhance contrast in photoacoustic images at clinically relevant depths. However, CuS NPs are not efficient optical absorbers when compared to plasmonic nanoparticles and therefore, contrast enhancement with CuS NPs is limited, requiring high concentrations to generate images with sufficient signal-to-noise ratio. We have combined CuS NPs with laser-activated perfluorocarbon nanodroplets (PFCnDs) to achieve enhanced photoacoustic contrast and, more importantly, ultrasound contrast while retaining the favorable clinical characteristics of CuS NPs. The imaging characteristics of synthesized CuS-PFCnD constructs were first tested in tissue-mimicking phantoms and then in in vivo murine models. The results demonstrate that CuS-PFCnDs enhance contrast in photoacoustic (PA) and ultrasound (US) imaging. Upon systemic administration in vivo, CuS-PFCnDs remain stable and their unique vaporization provides sufficient PA/US contrast that can be further exploited for contrast-enhanced background-free imaging. The conducted studies provide a solid foundation for further development of CuS-PFCnDs as PA/US diagnostic and eventually therapeutic agents for clinical applications.

[1]  Kullervo Hynynen,et al.  Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. , 2003, Ultrasound in medicine & biology.

[2]  Matthew O'Donnell,et al.  Nonlinear contrast enhancement in photoacoustic molecular imaging with gold nanosphere encapsulated nanoemulsions. , 2014, Applied physics letters.

[3]  Feng Chen,et al.  Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics. , 2014, Small.

[4]  Fan Zhang,et al.  Preclinical Lymphatic Imaging , 2011, Molecular Imaging and Biology.

[5]  Sai T Reddy,et al.  In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[6]  M. C. Mancini,et al.  Bioimaging: second window for in vivo imaging. , 2009, Nature nanotechnology.

[7]  Stanislav Emelianov,et al.  Indocyanine green-loaded photoacoustic nanodroplets: dual contrast nanoconstructs for enhanced photoacoustic and ultrasound imaging. , 2014, ACS nano.

[8]  Wei Lu,et al.  A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity. , 2013, ACS nano.

[9]  Stanislav Emelianov,et al.  Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies , 2015, Annals of Biomedical Engineering.

[10]  Stanislav Emelianov,et al.  Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging , 2012, Nature Communications.

[11]  Dong Liang,et al.  CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy. , 2015, ACS nano.

[12]  Dong Liang,et al.  A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. , 2010, Journal of the American Chemical Society.

[13]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[14]  Stanislav Emelianov,et al.  Enhanced thermal stability of silica-coated gold nanorods for photoacoustic imaging and image-guided therapy , 2010, Optics express.

[15]  Qian Huang,et al.  Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. , 2012, ACS nano.

[16]  G. Storm,et al.  Liposomes to target the lymphatics by subcutaneous administration. , 2001, Advanced drug delivery reviews.

[17]  S. Emelianov,et al.  Super-Resolution Ultrasound Imaging in Vivo with Transient Laser-Activated Nanodroplets. , 2016, Nano letters.

[18]  Wei Lu,et al.  Copper sulfide nanoparticles for photothermal ablation of tumor cells. , 2010, Nanomedicine.

[19]  T. Tamura,et al.  Functions and development of red pulp macrophages , 2015, Microbiology and immunology.

[20]  S M Moghimi,et al.  Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. , 2012, Annual review of pharmacology and toxicology.

[21]  Jinwoo Cheon,et al.  Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. , 2008, Accounts of chemical research.

[22]  M. Cataldi,et al.  Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes , 2017, International journal of molecular sciences.

[23]  Ji-ming Xu,et al.  Facile fabrication of ultrasmall and uniform copper nanoparticles , 2011 .

[24]  S. Caruthers,et al.  19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  N. Rapoport.  Drug-Loaded Perfluorocarbon Nanodroplets for Ultrasound-Mediated Drug Delivery. , 2016, Advances in experimental medicine and biology.

[26]  Samir Mitragotri,et al.  A Review of Clinical Translation of Inorganic Nanoparticles , 2015, The AAPS Journal.

[27]  R. Zemp,et al.  Porphyrin Nanodroplets: Sub-micrometer Ultrasound and Photoacoustic Contrast Imaging Agents. , 2016, Small.

[28]  J B Fowlkes,et al.  Acoustic droplet vaporization for therapeutic and diagnostic applications. , 2000, Ultrasound in medicine & biology.

[29]  Paul A Dayton,et al.  Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[30]  M. Detmar,et al.  Inflammation-induced lymph node lymphangiogenesis is reversible. , 2012, The American journal of pathology.

[31]  Michael Detmar,et al.  The cutaneous vascular system in chronic skin inflammation , 2011, The journal of investigative dermatology. Symposium proceedings.

[32]  Peter N. Burns,et al.  Ultrasound for the Visualization and Quantification of Tumor Microcirculation , 2004, Cancer and Metastasis Reviews.

[33]  A. Klibanov,et al.  Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. , 1999, Advanced drug delivery reviews.

[34]  F. Granata,et al.  Angiogenesis and lymphangiogenesis in inflammatory skin disorders. , 2015, Journal of the American Academy of Dermatology.

[35]  Elizabeth Huynh,et al.  Multimodal micro, nano, and size conversion ultrasound agents for imaging and therapy. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[36]  S. Emelianov,et al.  Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. , 2011, Trends in biotechnology.

[37]  Donald VanderLaan,et al.  Photoacoustic and ultrasound imaging using dual contrast perfluorocarbon nanodroplets triggered by laser pulses at 1064 nm. , 2014, Biomedical optics express.

[38]  Jan Grimm,et al.  Nanoparticles for imaging: top or flop? , 2014, Radiology.